Moreover, resistance of cancer cells to cytolytic CAPs is unlikely, because CAPs are attracted to many negatively-charged surface molecules rather than interacting with a unique receptor; to our knowledge, cancer cell resistance to lytic CAPs has never been documented. The gene discussed is CAPS; the disease is cancer.